The overexpression of ABCG2 in these subpopulations of stem cells was also reported among other tumors such as neuroblastomas, Ewing sarcomas, breast cancer, small cell lung cancer, and glioblastomas (Hirschmann-Jax et al., 2004). This evidence concerns the gene ABCG2 and breast carcinoma.